Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Sumpless Pump System: Reduce Floor Space Requirements

Sumps, which are pits or underground tanks used to collect water, have long been the traditional method of collecting wastewater, but they’re far from effective. Not only are they financially inefficient, sumps leave businesses vulnerable to worker safety risks, such as wet floors — not to mention the pungently unpleasant odor of wastewater, as well…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Sumps, which are pits or underground tanks used to collect water, have long been the traditional method of collecting wastewater, but they’re far from effective. Not only are they financially inefficient, sumps leave businesses vulnerable to worker safety risks, such as wet floors — not to mention the pungently unpleasant odor of wastewater, as well as requiring excess floor space.

Failing Sumps Lead to Wastewater Spills

Sumps should work to remove water that has accumulated in a water-collecting basin, but when they fail, the water must go somewhere—unfortunately, it’s typically funneled into our water sources. According to a U.S. News & World Report article, in 2017, an equipment failure at a Seattle plant dumped over 30 million gallons of sewage into Puget Sound. These types of spills have health, environmental, and monetary consequences. The truth is that sumps can fail and lead to wastewater spills.

How Sumpless Collection Works

DMP Corporation offers a sumpless solution, the first of its kind. Using sensors that determine when it’s time for the water to be pumped to a holding tank for treatment, the DMP system retains wastewater in a pipe that keeps the area under wet process relatively dry, thereby reducing odor and safety concerns while offering tremendous cost savings. Because waste is collected as it’s generated, the need for pits or underground tanks is eliminated. DMP’s sumpless solution also offers the option for automated waste segregation, with sensors (ph, conductivity, etc.). The trench with pipe can qualify as secondary containment too.

Sumpless Works as a Retrofit

DMP connects dual in-line pumps to manifolds, transferring the waste directly to the rinse water or spent solution tanks which are fitted with automatic control valves. Not only does this remove the need for sumps, it avoids RCRA mandated double containment. And because DMP’s sumpless collection connects easily to existing process piping headers, businesses will not incur added expenses to make the switch. And proper sizing at installation ensures long-term, hassle-free operation.

Rely on DMP for Sumpless Collection

Often ineffective and costly, sumps have been used for years in the wastewater treatment ecosystem. Offering many benefits, sumpless wastewater treatment is a new way to take on an old problem. The DMP solution pioneers this new approach at automating wastewater, saving organizations money while reducing the floor space requirement, eliminating safety hazards, and reducing fetid odors.

Read more at dmpcorp.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512